Advertisement

Topics

Cardiovascular Systems Inc. Company Profile

01:05 EST 20th November 2017 | BioPortfolio

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s Stealth 360°™, Diamondback 360® and Diamondback Predator 360® Orbital PAD Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. The U.S. FDA granted 510(k) clearance for the use of the Diamondback 360° in August 2007 and for the Stealth 360° in March 2011. To date, more than 37,000 PAD procedures have been performed using the Diamondback 360° in leading institutions across the United States.


News Articles [804 Associated News Articles listed on BioPortfolio]

HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology

HDL-cholesterol levels in plasma predict the risk of cardiovascular disease, but a direct causal role for HDL in cardiovascular disease remains controversial. In this Review, Rosenson et al. discuss ...

The unexpected role of a well-known gene in creating blood

One of the first organ systems to form and function in the embryo is the cardiovascular system: in fact, this developmental process starts so early that scientists still have many unresolved questions...

Cardiovascular Systems (CSII) Presents At JMP Securities Life Sciences Conference - Slideshow

Cardiovascular Systems' (CSII) CEO Scott Ward on Q1 2018 Results - Earnings Call Transcript

Cardiovascular Systems (CSII) Presents At CFA Society Of Minnesota 6th Annual Intellisight Conference - Slideshow

Shareholders Revive Class-Action Suit Against Cardiovascular Systems

  Life Sciences Jobs   ...

Cardiovascular Systems Touts 1-year, Sub-Analysis Data from Liberty PVI Study

  Life Sciences Jobs   ...

Cardiovascular Systems (CSII) Presents At Lake Street Capital Best Ideas Growth Conference - Slideshow

PubMed Articles [2730 Associated PubMed Articles listed on BioPortfolio]

Objective cardiovascular assessment in the neonatal intensive care unit.

Traditionally, cardiovascular well-being was essentially based on whether the mean blood pressure was above or below a certain value. However, this singular crude method of assessment provides limited...

Prevalence of depression in cardiovascular patients in Iran: A systematic review and meta-analysis from 2000 to 2017.

In both developed and developing countries, cardiovascular disease is on the rise, representing nowadays one of the main challenges for the health systems worldwide. This increase generates relevant c...

Bidirectional asymmetry in the neurovisceral communication for the cardiovascular control: New insights.

The cardiovascular control involves a bidirectional functional connection between the brain and heart. We hypothesize that this connection could be extended to other organs using endocrine and autonom...

Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference.

The need for novel approaches to cardiovascular drug development served as the impetus to convene an open meeting of experts from the pharmaceutical industry and academia to assess the challenges and ...

Cardiovascular Disease in Korean Americans: A Systematic Review.

Despite Korean Americans being one of the fastest growing immigrant groups in the United States, little is known about their cardiovascular health or cardiovascular disease risk factors.

Clinical Trials [3294 Associated Clinical Trials listed on BioPortfolio]

Alterations in Autonomic Cardiovascular Control Induced at Partial G Forces

As a direct consequence of exposure to microgravity, astronauts experience a number of physiological changes which can lead to serious medical implications. Most immediate and significant ...

Childhood Passive Smoking: Cohort Study of Cardiac Risk

To determine the effects of long-term exposure to passive smoking on the cardiovascular and oxygen transport systems in pre-adolescent twins.

Mobile Cardiovascular Risk Service Trial

Risk factors for cardiovascular disease are poorly controlled even for patients who frequently visit their physician, leading to large numbers of preventable cardiovascular events such as ...

Reducing PM-associated CV Health Effects for Seniors

The objective of this study is to investigate the effectiveness of air filtration at reducing personal-level exposures to fine particulate matter (PM2.5) and mitigating related cardiovascu...

Postpartum Immediate Contraception in Cesarean Deliveries-Comparison of Two Intrauterine Systems

To compare two intrauterine systems in order to avoid complications originating from short pregnancy interval and undesired pregnancies in the early postpartum period.

Companies [1903 Associated Companies listed on BioPortfolio]

Ra Medical Systems

Ra Medical Systems was founded in 2002 to commercialize excimer lasers for the treatment of dermatologic and cardiovascular diseases. Its flagship product, Pharos, launched in 200...

Cardiovascular Consultants, Ltd.

Cardiovascular Consultants, Ltd., founded in 1986 by Dr. Andrei Damian, is dedicated to providing patients in Phoenix and surrounding areas with the most advanced and appropriate ...

Cardiovascular Consultants Ltd.

Cardiovascular Consultants Ltd., founded in 1986 by Dr. Andrei Damian, is dedicated to providing patients in Phoenix and surrounding areas with the most advanced and appropriate c...

Embrella Cardiovascular, Inc.

Embrella Cardiovascular™, Inc., is dedicated to creating a new standard-of-care for cerebral embolic protection during cardiovascular procedures. Embrella's Embolic Deflector...

ProSolv CardioVascular

Founded in 1989 as Problem Solving Concepts, Inc. (ProSolv) and acquired by FUJIFILM Medical Systems in January 2007, the company is a leading provider of enterprise-level information management solut...

More Information about "Cardiovascular Systems Inc." on BioPortfolio

We have published hundreds of Cardiovascular Systems Inc. news stories on BioPortfolio along with dozens of Cardiovascular Systems Inc. Clinical Trials and PubMed Articles about Cardiovascular Systems Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cardiovascular Systems Inc. Companies in our database. You can also find out about relevant Cardiovascular Systems Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...


Corporate Database Quicklinks



Searches Linking to this Company Record